Entrada Therapeutics Inc - TRDA - stock price prediction, stock price target, analyst ratings from 7 analysts

Entrada Therapeutics Inc has a share price target of US$ 20, revenue growth forecast of -2.0%, and profit growth estimate of -24.8% for FY26, based on top 7 analyst calls.